Effects of the anticonvulsant lacosamide compared to valproate and lamotrigine on cocaine-enhanced reward in rats

Brain Research

Volumn 1479, Issue , 2012, Pages 44-51

  Béguin, Cécile ^a,b   Potter, David N ^a   Carlezon, William A ^a,b   Stöhr, Thomas ^c   Cohen, Bruce M ^a,b  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c A2M Pharma GmbH   (Germany)

Author keywords

Cocaine; ICSS; Lacosamide; Lamotrigine; Reward; Valproate

Indexed keywords

COCAINE; HARKOSERIDE; LAMOTRIGINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG DOSE COMPARISON; DRUG EFFECT; MALE; MOOD; MOTIVATION; NERVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REWARD;

RATTUS;

EID: 84866991951     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.08.030     Document Type: Article

References (32)

1. R. Arban, G. Maraia, K. Brackenborough, L. Winyard, A. Wilson, P. Gerrard, and C. Large Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania Behav. Brain Res. 158 2005 123 132
2. C.E. Begley, J.F. Annegers, A.C. Swann, C. Lewis, S. Coan, W.B. Schnapp, and L. Bryant-Comstock The lifetime cost of bipolar disorder in the US: an estimate for new cases in 1998 Pharmacoeconomics 19 2001 483 495
3. M. Berk Lamotrigine and the treatment of mania in bipolar disorder Eur. Neuropsychopharmacol. 9 Suppl 4 1999 S119 123
4. B.K. Beyreuther, J. Freitag, C. Heers, N. Krebsfanger, U. Scharfenecker, and T. Stohr Lacosamide: a review of preclinical properties CNS Drug Rev. 13 2007 21 42
5. C.L. Bowden Anticonvulsants in bipolar disorders: current research and practice and future directions Bipolar Disord. 11 Suppl 2 2009 20 33
6. C.L. Bowden, and V. Singh Valproate in bipolar disorder: 2000 onwards Acta Psychiatr. Scand. Suppl. 2005 13 20
7. J.R. Calabrese, R.F. Huffman, R.L. White, S. Edwards, T.R. Thompson, J.A. Ascher, E.T. Monaghan, and R.A. Leadbetter Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials Bipolar Disord. 10 2008 323 333
8. B.J. Cao, and N.A. Peng Magnesium valproate attenuates hyperactivity induced by dexamphetamine-chlordiazepoxide mixture in rodents Eur. J. Pharmacol. 237 1993 177 181
9. W.A. Carlezon Jr.; C. Beguin, J.A. DiNieri, M.H. Baumann, M.R. Richards, M.S. Todtenkopf, R.B. Rothman, Z. Ma, D.Y. Lee, and B.M. Cohen Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats J. Pharmacol. Exp. Ther. 316 2006 440 447
10. W.A. Carlezon Jr.; and E.H. Chartoff Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation Nat. Protoc. 2 2007 2987 2995
11. R.S. El-Mallakh, and M.O. Huff Mood stabilizers and ion regulation Harv. Rev. Psychiatry 9 2001 23 32
12. A.C. Errington, T. Stohr, C. Heers, and G. Lees The investigational anticonvulsant lacosamide selectively enhances slow inactivation of voltage-gated sodium channels Mol. Pharmacol. 73 2008 157 169
13. J.R. Geddes, J.R. Calabrese, and G.M. Goodwin Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials Br. J. Psychiatry 194 2009 4 9
14. T.D. Gould, J.A. Quiroz, J. Singh, C.A. Zarate Jr.; and H.K. Manji Emerging experimental therapeutics for bipolar disorder: insights from the molecular and cellular actions of current mood stabilizers Mol. Psychiatry 9 2004 734 755
15. M.P. Kelly, S.F. Logue, J.M. Dwyer, C.E. Beyer, H. Majchrowski, Z. Cai, Z. Liu, A. Adedoyin, S. Rosenzweig-Lipson, and T.A. Comery The supra-additive hyperactivity caused by an amphetamine-chlordiazepoxide mixture exhibits an inverted-U dose response: negative implications for the use of a model in screening for mood stabilizers Pharmacol. Biochem. Behav. 92 2009 649 654
16. C. Lennkh, and C. Simhandl Current aspects of valproate in bipolar disorder Int. Clin. Psychopharmacol. 15 2000 1 11
17. K.A. Macritchie, J.R. Geddes, J. Scott, D.R. Haslam, and G.M. Goodwin Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder Cochrane Database Syst. Rev.3, Art. No. 2001 CD003196
18. S.D. Mague, S.L. Andersen, and W.A. Carlezon Jr. Early Developmental exposure to methylphenidate reduces cocaine-induced potentiation of brain stimulation reward in rats Biol. Psychiatry 57 2005 120 125
19. M. Mavrikaki, G.G. Nomikos, and G. Panagis Effects of mood stabilizers on brain reward processes in rats: studies using the intracranial self-stimulation paradigm Eur. Neuropsychopharmacol. 19 2009 205 214
20. C.L. Melvin, T.S. Carey, F. Goodman, J.M. Oldham, J.W. Williams Jr.; and L.M. Ranney Effectiveness of antiepileptic drugs for the treatment of bipolar disorder: findings from a systematic review J. Psychiatr. Pract. 14 Suppl 1 2008 9 14
21. K.D. Park, P. Morieux, C. Salome, S.W. Cotten, O. Reamtong, C. Eyers, S.J. Gaskell, J.P. Stables, R. Liu, and H. Kohn Lacosamide isothiocyanate-based agents: novel agents to target and identify lacosamide receptors J. Med. Chem. 52 2009 6897 6911
22. G. Paxinos, and C. Watson The Rat Brain in Stereotaxic Coordinates second ed. 1986 Academic Press San Diego, CA
23. R. Rushton, and H. Steinberg Combined effects of chlordiazepoxide and dexamphetamine on activity of rats in an unfamiliar environment Nature 211 1966 1312 1313
24. P.L. Sheets, C. Heers, T. Stoehr, and T.R. Cummins Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2 R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine J. Pharmacol. Exp. Ther. 326 2008 89 99
25. S.M. Stahl Anticonvulsants as mood stabilizers and adjuncts to antipsychotics: valproate, lamotrigine, carbamazepine, and oxcarbazepine and actions at voltage-gated sodium channels J. Clin. Psychiatry 65 2004 738 739
26. T. Stohr, H.J. Kupferberg, J.P. Stables, D. Choi, R.H. Harris, H. Kohn, N. Walton, and H.S. White Lacosamide, a novel anti-convulsant drug, shows efficacy with a wide safety margin in rodent models for epilepsy Epilepsy Res. 74 2007 147 154
27. M.S. Todtenkopf, J.F. Marcus, P.S. Portoghese, and W.A. Carlezon Jr. Effects of kappa-opioid receptor ligands on intracranial self-stimulation in rats Psychopharmacology (Berlin) 172 2004 463 470
28. H.C. Tomasiewicz, M.S. Todtenkopf, E.H. Chartoff, B.M. Cohen, and W.A. Carlezon Jr. The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward Biol. Psychiatry 64 2008 982 988
29. M.L. van der Loos, P.G. Mulder, E.G. Hartong, M.B. Blom, A.C. Vergouwen, H.J. de Keyzer, P.J. Notten, M.L. Luteijn, M.A. Timmermans, E. Vieta, and W.A. Nolen Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: a multicenter, double-blind, placebo-controlled trial J. Clin. Psychiatry 70 2009 223 231
30. Y. Wang, J.M. Brittain, B.W. Jarecki, K.D. Park, S.M. Wilson, B. Wang, R. Hale, S.O. Meroueh, T.R. Cummins, and R. Khanna In silico docking and electrophysiological characterization of lacosamide binding sites on collapsin response mediator protein-2 identifies a pocket important in modulating sodium channel slow inactivation J. Biol. Chem. 285 2010 25296 25307
31. H.S. White Mechanism of action of newer anticonvulsants J. Clin. Psychiatry 64 Suppl 8 2003 5 8
32. X. Xie, and R.M. Hagan Cellular and molecular actions of lamotrigine: possible mechanisms of efficacy in bipolar disorder Neuropsychobiology 38 1998 119 130